Aquilo Capital Management as of Dec. 31, 2023
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 10 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals (ARWR) | 17.3 | $28M | 909k | 30.60 | |
| Blueprint Medicines (BPMC) | 14.6 | $24M | 255k | 92.24 | |
| Kymera Therapeutics (KYMR) | 14.0 | $22M | 881k | 25.46 | |
| Arvinas Ord (ARVN) | 12.5 | $20M | 489k | 41.16 | |
| Silence Therapeutics Ads (SLN) | 11.3 | $18M | 1.0M | 17.37 | |
| S&p Biotech Etf Tr Unit Put Option (XBI) | 11.1 | $18M | 200k | 89.29 | |
| Regenxbio Inc equity us cm (RGNX) | 9.0 | $14M | 802k | 17.95 | |
| Merus N V (MRUS) | 6.1 | $9.8M | 355k | 27.50 | |
| Repare Therapeutics Ord (RPTX) | 2.9 | $4.6M | 633k | 7.30 | |
| Sutro Biopharma (STRO) | 1.1 | $1.8M | 421k | 4.29 |
